These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29426656)

  • 1. A rapid lateral flow immunoassay for serological diagnosis of pertussis.
    Salminen T; Knuutila A; Barkoff AM; Mertsola J; He Q
    Vaccine; 2018 Mar; 36(11):1429-1434. PubMed ID: 29426656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of an Australian pertussis toxin IgG and IgA enzyme immunoassay.
    May ML; Doi SA; King D; Evans J; Robson JM
    Clin Vaccine Immunol; 2012 Feb; 19(2):190-7. PubMed ID: 22131356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole blood based point-of-care assay for the detection of anti-pertussis toxin IgG antibodies.
    Knuutila A; Rautanen C; Barkoff AM; Mertsola J; He Q
    J Immunol Methods; 2022 Nov; 510():113361. PubMed ID: 36179606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral fluid-based lateral flow point-of-care assays for pertussis serology.
    Knuutila A; Duncan J; Li F; Eletu S; Litt D; Fry N; He Q
    J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36763084
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and validation of an Australian in-house anti-pertussis toxin IgG and IgA enzyme immunoassay.
    May ML; Evans J; Riley J; Lambkin G; Robson JM
    Pathology; 2013 Feb; 45(2):172-80. PubMed ID: 23250035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of commercial serological assays measuring Bordetella pertussis IgG antibodies.
    Fedele G; Leone P; Bellino S; Schiavoni I; Pavia C; Lazzarotto T; Stefanelli P
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):157-162. PubMed ID: 29221733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].
    Gürsel D; Aslan A; Sönmez C; Koturoğlu G; Cöplü N; Kurugöl Z; Aydemir S
    Mikrobiyol Bul; 2012 Apr; 46(2):211-24. PubMed ID: 22639310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories.
    Guiso N; Berbers G; Fry NK; He Q; Riffelmann M; Wirsing von König CH;
    Eur J Clin Microbiol Infect Dis; 2011 Mar; 30(3):307-12. PubMed ID: 21069406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of IgA, IgM and IgG antibody-detecting assays based on filamentous haemagglutinin, pertussis toxin and Bordetella pertussis sonicate in a strictly adult population.
    Klement E; Kagan N; Hagain L; Kayouf R; Boxman J; Cohen D; Orr N
    Epidemiol Infect; 2005 Feb; 133(1):149-58. PubMed ID: 15724722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
    Prince HE; Lapé-Nixon M; Matud J
    Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in serological diagnosis of pertussis by external quality assessment.
    Markey K; Douglas-Bardsley A; Asokanathan C; Fry NK; Barkoff AM; Bacci S; Ködmön C; He Q
    J Med Microbiol; 2019 May; 68(5):741-747. PubMed ID: 30990403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
    Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I
    Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT).
    Lee AD; Cassiday PK; Pawloski LC; Tatti KM; Martin MD; Briere EC; Tondella ML; Martin SW;
    PLoS One; 2018; 13(4):e0195979. PubMed ID: 29652945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of anti-pertussis toxin ELISA and agglutination assays to assess immune responses to pertussis.
    Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
    Infect Dis (Lond); 2017 Aug; 49(8):594-600. PubMed ID: 28335677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
    Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.
    Baughman AL; Bisgard KM; Edwards KM; Guris D; Decker MD; Holland K; Meade BD; Lynn F
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1045-53. PubMed ID: 15539504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of Immunoglobulin G Antibodies Against Pertussis Toxin Does Not Decrease Over a Long Period of Time in Japan.
    Sakakibara Y; Ohtani Y; Jinta T; Fujie T; Miyazaki Y; Inase N; Saito R; Akaza M; Sasano T; Sumi Y
    Intern Med; 2016; 55(22):3257-3263. PubMed ID: 27853066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.
    Kapasi A; Meade BD; Plikaytis B; Pawloski L; Martin MD; Yoder S; Rock MT; Coddens S; Haezebroeck V; Fievet-Groyne F; Bixler G; Jones C; Hildreth S; Edwards KM; Messonnier NE; Tondella ML
    Clin Vaccine Immunol; 2012 Jan; 19(1):64-72. PubMed ID: 22116688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis.
    Oguchi K; Miyata A; Kazuyama Y; Noda A; Suzuki E; Watanabe M; Nakayama T
    J Infect Chemother; 2015 Sep; 21(9):639-46. PubMed ID: 26134278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-component cluster analysis of a large serodiagnostic database for specificity of increases of IgG antibodies against pertussis toxin in paired serum samples and of absolute values in single serum samples.
    de Greeff SC; Teunis P; de Melker HE; Mooi FR; Notermans DW; Elvers B; Schellekens JF
    Clin Vaccine Immunol; 2012 Sep; 19(9):1452-6. PubMed ID: 22787194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.